The Effect of the FDA VVarning on the Use of Droperidol by U.S. Emergency Physicians
General Material Designation
[Article]
First Statement of Responsibility
Richards, John R; Weiss, Steven J; Bretz, Stephen W; Schneir, Aaron B; Rinetti, Dauna; Derlet, Robert W
SUMMARY OR ABSTRACT
Text of Note
Objectives: To determine if emergency physicians' (EP) use droperidol has changed since the United States Food and Drug Administration (FDA) warning of December 2001 concerning QT interval prolongation, torsade de pointes, and sudden death; and to query EP opinions regarding droperidol before and after the FDA warning and regarding potential alternative drugs.
SET
Date of Publication
2003
Title
Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health
Volume Number
4/1
PERSONAL NAME - PRIMARY RESPONSIBILITY
Entry Element
Richards, John R; Weiss, Steven J; Bretz, Stephen W; Schneir, Aaron B; Rinetti, Dauna; Derlet, Robert W